Drug General Information
Drug ID	D0S5OR
Former ID	DNC014195
Drug Name	(+/-)-Daedalin A
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530600]
Structure		Download 2D MOL 3D MOL
Formula	C11H12O3
Canonical SMILES	CC1(C=CC2=C(O1)C=CC(=C2)O)CO
InChI	1S/C11H12O3/c1-11(7-12)5-4-8-6-9(13)2-3-10(8)14-11/h2-6,12-13H,7H2,1H3/t11-/m1/s1
InChIKey	LTKJWSBGTNWRNP-LLVKDONJSA-N
PubChem Compound ID	46230831
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[530600]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 530600	Bioorg Med Chem Lett. 2010 Feb 1;20(3):1063-4. Epub 2009 Dec 11.Asymmetric syntheses of daedalin A and quercinol and their tyrosinase inhibitory activity.
Ref 530600	Bioorg Med Chem Lett. 2010 Feb 1;20(3):1063-4. Epub 2009 Dec 11.Asymmetric syntheses of daedalin A and quercinol and their tyrosinase inhibitory activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.